Editorial: Role of Neuroinflammation in the Neuropsychiatric and Neurological Aspects of COVID-19

Front Cell Neurosci. 2022 Feb 9:16:840121. doi: 10.3389/fncel.2022.840121. eCollection 2022.

Marie-Eve Tremblay^{1

2

3

4

5}, Charlotte Madore⁶, Li Tian^{7

8}, Alexei Verkhratsky^{9

10

11

12}

¹ Axe Neurosciences, Centre de Recherche du CHU de Québec, Université Laval, Québec City, QC, Canada.
² Neurology and Neurosurgery Department, McGill University, Montréal, QC, Canada.
³ Department of Molecular Medicine, Université Laval, Québec City, QC, Canada.
⁴ Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.
⁵ Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, BC, Canada.
⁶ Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286, Bordeaux, France.
⁷ Department of Physiology, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
⁸ Psychiatry Research Centre, Beijing Huilongguan Hospital, Peking University Health Science Center, Beijing, China.
⁹ Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
¹⁰ Achucarro Center for Neuroscience, IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
¹¹ Department of Neurosciences, University of the Basque Country UPV/EHU and CIBERNED, Leioa, Spain.
¹² Sechenov First Moscow State Medical University, Moscow, Russia.

No abstract available

Keywords: COVID-19; SARS-CoV-2; aging; astrocytes; comorbidity; development; microglia; oligodendrocytes.

Publication types